Inflammatory Conditions

Section 2 - Inflammatory Conditions

Published online by Cambridge University Press: 15 June 2018

Edited by

Louis Caplan and

José Biller

Show author details

Louis Caplan: Affiliation:
Beth Israel-Deaconess Medical Center, Boston
José Biller: Affiliation:
Loyola University Stritch School of Medicine, Chicago

Book contents

Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type: Chapter
Information: Uncommon Causes of Stroke , pp. 77 - 118

DOI: https://doi.org/10.1017/9781316551684 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Alhalabi, M. and Moore, P. M. 1994. Serial angiography in isolated angiitis of the central nervous system. Neurology, 44, 1221–6.CrossRef Google Scholar PubMed

Alreshaid, A. A. and Powers, W. J. 2003. Prognosis of patients with suspected primary CNS angiitis and negative brain biopsy. Neurology, 61, 831–3.10.1212/01.WNL.0000081047.22043.ABCrossRef Google Scholar PubMed

Amlie-Lefond, C. and Gilden, D. 2016. Varicella zoster virus: A common cause of stroke in children and adults. J Stroke Cerebrovasc Dis, 25, 1561–69.CrossRef Google Scholar PubMed

Arthur, G., and Margolis, G. 1977. Mycoplasma-like structures in granulomatous angiitis of the central nervous system: Case reports with light and electron microscope studies. Arch Pathol Lab Med, 101, 382–7.Google Scholar

Benseler, S. M., de Veber, G., Hawkins, C., et al. 2005. Angiography-negative primary central nervous system vasculitis in children. Arthritis Rheum, 52, 2159–67.10.1002/art.21144CrossRef Google Scholar PubMed

Benseler, S. M., Silverman, E., Aviv, R. I., et al. 2006. Primary central nervous system vasculitis in children. Arthritis Rheum, 54, 1291–7.10.1002/art.21766CrossRef Google Scholar PubMed

Bhibhatbhan, A., Katz, N. R., Hudon, M., et al. 2006. Primary angiitis of the spinal cord presenting as a conus mass: Long term remission. Surg Neurol, 66, 622–5.10.1016/j.surneu.2006.01.023CrossRef Google Scholar PubMed

Calabrese, L. H. and Mallek, J. A. 1988. Primary angiitis of the central nervous system. Report of 8 cases, review of the literature and proposal for diagnostic criteria. Medicine, 108, 815–23.Google Scholar

Calabrese, L. H., Duna, G. F., and Lie, J. T. 1997. Vasculitis in the central nervous system. Arthritis Rheum, 40, 1189–201.3.0.CO;2-4>CrossRef Google Scholar PubMed

Call, G. K., Fleming, M. C., Sealfon, S., et al. 1988. Reversible cerebral segmental vasoconstriction. Stroke, 19, 1159–70.CrossRef Google Scholar PubMed

Canhao, H., Fonseca, J. E., and Rosa, A. 2000. Intravenous gammaglobulin in the treatment of central nervous system vasculitis associated with Sjogren’s syndrome. J Rheumatol, 27, 1102–3.Google Scholar PubMed

Chu, C. T., Gray, L., Goldstein, L. B., and Hulette, C. M. 1998. Diagnosis of intracranial vasculitis: A multi-disciplinary approach. J Neuropathol Exp Neurol, 57, 30–8.10.1097/00005072-199801000-00005CrossRef Google Scholar PubMed

Cravioto, H. and Feigin, I. 1959. Noninfectious granulomatous angiitis with a predilection for the nervous system. Neurology, 9, 599–609.10.1212/WNL.9.9.599CrossRef Google Scholar PubMed

De Boysson, H., Zuber, M., Naggara, O., et al. 2014. Primary angiitis of the central nervous system: Description of the first fifty-two adults enrolled in the French cohort of patients with primary vasculitis of the central nervous system. Arthritis Rheumatol, 66, 1315–26.CrossRef Google Scholar PubMed

Ducros, A., Boukobza, M., Porcher, A., et al. 2007. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain, 130, 3091–101.CrossRef Google Scholar PubMed

Duna, G. and Calabrese, L. H. 1995. Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol, 22, 662–7.Google Scholar PubMed

Ehsan, T., Hasan, S., Powers, J. M., and Heiserman, J. E. 1995. Serial magnetic resonance imaging in isolated angiitis of the central nervous system. Neurology, 45, 1462–5.10.1212/WNL.45.8.1462CrossRef Google Scholar PubMed

Finelli, P. F., Onyiuke, H. C., and Uphoff, D. F. 1997. Idiopathic granulomatous angiitis of the CNS manifesting as diffuse white matter disease. Neurology, 49, 1696–9.10.1212/WNL.49.6.1696CrossRef Google Scholar PubMed

Fountain, N. B. and Eberhard, D. A. 1996. Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: Report of two cases and review of the literature. Neurology, 46, 190–7.10.1212/WNL.46.1.190CrossRef Google Scholar PubMed

Gilden, D. H., Kleinschmidt-DeMasters, B. K., Wellish, M., et al. 1996. Varicella zoster virus, a cause of waxing and waning vasculitis: New England Journal of Medicine case 5–1995 revisited. Neurology, 47, 1441–6.10.1212/WNL.47.6.1441CrossRef Google Scholar PubMed

Harrison, P. E. 1976. Granulomatous angiitis of the central nervous system. Case report and review. J Neurol Sci, 29, 335–41.CrossRef Google Scholar PubMed

Hellmann, D. B., Roubenoff, R., Healy, R. A., and Wang, H. 1992. Central nervous system angiography: Safety and predictors of a positive result in 125 consecutive patients evaluated for possible vasculitis. J Rheumatol, 19, 568–72.Google Scholar PubMed

Hunn, M., Robinson, S., Wakefield, L., Mossman, S., and Abernethy, D. 1998. Granulomatous angiitis of the CNS causing spontaneous intracerebral haemorrhage: The importance of leptomeningeal biopsy. J Neurol Neurosurg Psychiatry, 65, 956–7.CrossRef Google Scholar PubMed

Hutchinson, C., Elbers, J., Halliday, W., et al. 2010. Treatment of small vessel primary CNS vasculitis in children: An open-label cohort study. Lancet Neurol, 9, 1078–84.CrossRef Google Scholar PubMed

Iancu-Gontard, D., Oppenheim, C., Touzé, E., et al. 2003. Evaluation of hyperintense vessels on FLAIR MRI for the diagnosis of intracerebral arterial stenoses. Stroke, 34, 1886–91.CrossRef Google Scholar PubMed

Johnson, M. D., Maciunas, R., Creasy, J., and Collins, R. D. 1994. Indolent granulomatous angiitis. J Neurosurg, 81, 472–6.CrossRef Google Scholar PubMed

Kadkhodayan, Y., Alreshaid, A., Moran, J. C., et al. 2004. Primary angiitis of the central nervous system at conventional angiography. Radiology, 233, 878–82.CrossRef Google Scholar PubMed

Koo, E. H. and Massey, E. W. 1988. Granulomatous angiitis of the central nervous system: Protean manifestations and response to treatment. J Neurol Neurosurg Psychiatry, 51, 1126–33.10.1136/jnnp.51.9.1126CrossRef Google Scholar PubMed

Kossorotoff, M., Touz, E., Godon-Hardy, S., et al. 2006. Cerebral vasculopathy with aneurysm formation in HIV-infected young adults. Neurology, 66, 1121–22.10.1212/01.wnl.0000204188.85402.0cCrossRef Google Scholar PubMed

Kumar, R., Wijdicks, E. F. M., Brown, R. D. Jr., Parisis, J. E., and Hammond, C. A. 1997. Isolated angiitis of the CNS presenting as subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry, 62, 649–51.CrossRef Google Scholar PubMed

Lanthier, S., Lortie, A., Michaud, J., et al. 2001. Isolated angiitis of the CNS in children. Neurology, 56, 837–42.10.1212/WNL.56.7.837CrossRef Google Scholar PubMed

Lie, J. T. 1992. Primary (granulomatous) angiitis of the central nervous system: A clinical pathologic analysis of 15 new cases and a review of the literature. Hum Pathol, 23, 164–71.10.1016/0046-8177(92)90238-XCrossRef Google Scholar

Linnemann, C. C. and Alvira, M. M. 1980. Pathogenesis of varicella-zoster angiitis in the CNS. Arch Neurol, 37, 239–40.CrossRef Google Scholar PubMed

Miller, D. H., Ormerod, I. E. C., Gibson, A., et al. 1987. MR brain scanning in patients with vasculitis: Differentiation from multiple sclerosis. Neuroradiology, 29, 226–31.10.1007/BF00451758CrossRef Google Scholar PubMed

Moore, P. M. 1989. Diagnosis and management of isolated angiitis of the central nervous system. Neurology, 39, 167–73.10.1212/WNL.39.2.167CrossRef Google Scholar PubMed

Moore, P. M. 1998. Central nervous system vasculitis. Curr Opin Neurol, 11, 241–6.Google Scholar PubMed

Moussaddy, A., Levy, A., Strbian, D., et al. 2015. Inflammatory cerebral amyloid angiopathy, amyloid-β-related angiitis, and primary angiitis of the central nervous system: Similarities and differences. Stroke, 46, e210–3.CrossRef Google Scholar PubMed

Negishi, C. and Sze, G. 1993. Vasculitis presenting as primary leptomeningeal enhancement with minimal parenchymal findings. AJNR Am J Neuroradiol, 14, 26–8.Google Scholar PubMed

Nishikawa, M., Sakamoto, H., Katsuyama, J., Hakuba, A., and Nishimura, S. 1998. Multiple appearing and vanishing aneurysms: Primary angiitis of the central nervous system. J Neurosurg, 88, 133–7.10.3171/jns.1998.88.1.0133CrossRef Google Scholar PubMed

Ohtake, T., Yoshida, H., Hirose, K., and Tanabe, H. 1989. Diagnostic value of the optic fundus in cerebral angiitis. J Neurol, 236, 490–1.10.1007/BF00328516CrossRef Google Scholar PubMed

Pierot, L., Chiras, J., Debussche-Depriester, C., Dormont, D., and Bories, J. 1991. Intracerebral stenoting arteriopathies. Contribution of three radiological techniques to the diagnosis. J Neuroradiol, 18, 32–48.Google Scholar PubMed

Rhodes, R. H., Madelaire, N. C., Petrelli, M., Cole, M., and Karaman, B. A. 1995. Primary angiitis and angiopathy of the central nervous system and their relationship to systemic giant cell arteritis. Arch Pathol Lab Med, 119, 334–9.Google Scholar PubMed

Riemer, G., Lamszus, K., Zschaber, R., et al. 1999. Isolated angiitis of the central nervous system: Lack of inflammation after long-term treatment. Neurology, 52, 196–9.CrossRef Google Scholar

Ritter, M. A., Dziewas, R., Papke, K., and Liemann, P. 2002. Follow-up examinations by transcranial doppler ultrasound in primary angiitis of the central nervous system. Cerebrovasc Dis, 14, 139–42.CrossRef Google Scholar PubMed

Salvarani, C., Brown, R. D. Jr, Calamia, K. T., et al. 2007. Primary central nervous system vasculitis: Analysis of 101 patients. Ann Neurol, 62, 442–51.CrossRef Google Scholar PubMed

Salvarani, C., Brown, R. D. Jr, and Hunder, G. G. 2012. Adult primary central nervous system vasculitis. Lancet, 380, 767–77.10.1016/S0140-6736(12)60069-5CrossRef Google Scholar PubMed

Salvarani, C., Hunder, G. G., Morris, J. M., et al. 2013. Aβ-related angiitis: Comparison with CAA without inflammation and primary CNS vasculitis. Neurology, 81, 1596–603.10.1212/WNL.0b013e3182a9f545CrossRef Google Scholar PubMed

Salvarani, C., Brown, R. D. Jr, Morris, J. M., et al. 2014. Catastrophic primary central nervous system vasculitis. Clin Exp Rheumatol, 32, S3–4.Google Scholar PubMed

Salvarani, C., Brown, R. D. Jr, Christianson, T. J., et al. 2015a. An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis. Description of 163 patients. Medicine (Baltimore), 94, e738.10.1097/MD.0000000000000738CrossRef Google Scholar

Salvarani, C., Pipitone, P., and Hunder, G. G. 2015b. Management of primary and secondary central nervous system vasculitis. Curr Opin Rheumatol, 28, 21–8.Google Scholar

Scolding, N. J., Joseph, F., Kirby, P. A., et al. 2005. Aβ-related angiitis: Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain, 128, 500–15.CrossRef Google Scholar PubMed

Wijdicks, E. F. M., Manno, E. M., Fulgham, J. R., and Giannini, C. 2003. Cerebral angiitis mimicking posterior leukoencephalopathy. J Neurol, 250, 444–8.10.1007/s00415-003-1021-4CrossRef Google Scholar PubMed

Zuber, M., Blustajn, J., Arquizan, C., et al. 1999. Angiitis of the central nervous system. J Neuroradiol, 26, 101–17.Google Scholar PubMed

Zuber, M., Touzé, E., Domigo, V., et al. 2006. Reversible cerebral angiopathy: Efficacy of nimodipine. J Neurol, 253, 1585–8.CrossRef Google Scholar PubMed

References

Achkar, AA, Lie, JT, Hunder, GG, O’Fallon, WM, Gabriel, SE. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994; 120: 987–92.10.7326/0003-4819-120-12-199406150-00003CrossRef Google Scholar PubMed

Alba, MA, Garcia-Martinez, A, Prieto-Gonzalez, S, et al. Relapses in patients with giant cell arteritis: Prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients. Medicine (Baltimore) 2014; 93: 194–201.CrossRef Google Scholar

Almarzouqi, SJ, Morgan, ML, Lee, AG. Treatment of giant cell arteritis. Curr Opin Ophthalmol 2015; 26: 469–75.10.1097/ICU.0000000000000201CrossRef Google Scholar PubMed

Amiri, N, De Vera, M, Choi, HK, Sayre, EC, Avina-Zubieta, JA. Increased risk of cardiovascular disease in giant cell arteritis: A general population-based study. Rheumatology (Oxford) 2016; 55: 33–40.10.1093/rheumatology/kev262CrossRef Google Scholar PubMed

Andersson, R, Malmvall, BE, Bengtsson, BA. Acute phase reactants in the initial phase of giant cell arteritis. Acta Med Scand 1986; 220: 365–7.CrossRef Google Scholar PubMed

Ball, EL, Walsh, SR, Tang, TY, Gohil, R, Clarke, JM. Role of ultrasonography in the diagnosis of temporal arteritis. Br J Surg 2010; 97: 1765–71.10.1002/bjs.7252CrossRef Google Scholar PubMed

Baslund, B, Helleberg, M, Faurschou, M, Obel, N. Mortality in patients with giant cell arteritis. Rheumatology (Oxford) 2015; 54: 139–43.10.1093/rheumatology/keu303CrossRef Google Scholar PubMed

Berti, A, Campochiaro, C, Cavalli, G, et al. Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity. Autoimmun Rev 2015; 14: 352–7.10.1016/j.autrev.2014.12.005CrossRef Google Scholar

Carmona, FD, Mackie, SL, Martin, JE, et al. A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility. Am J Hum Genet 2015; 96: 565–80.10.1016/j.ajhg.2015.02.009CrossRef Google Scholar

Caselli, RJ, Hunder, GG, Whisnant, JP. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1988; 38: 352–9.Google Scholar PubMed

Cavazza, A, Muratore, F, Boiardi, L, Restuccia, G, Pipitone, N, Pazzola, G, et al. Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol 2014; 38: 1360–70.CrossRef Google Scholar PubMed

Caylor, TL, Perkins, A. Recognition and management of polymyalgia rheumatica and giant cell arteritis. Am Fam Physician 2013; 88: 676–84.Google Scholar PubMed

Chandran, AK, Udayakumar, PD, Crowson, CS, Warrington, KJ, Matteson, EL. The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950–2009. Scand J Rheumatol 2015; 44: 215–8.10.3109/03009742.2014.982701CrossRef Google Scholar

Cid, MC, Font, C, Oristrell, J, et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998; 41: 26–32.10.1002/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-03.0.CO;2-0>CrossRef Google Scholar PubMed

Crowson, CS, Matteson, EL, Myasoedova, E, et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 2011; 63: 633–9.10.1002/art.30155CrossRef Google Scholar PubMed

Danesh-Meyer, H, Savino, PJ, Gamble, GG. Poor prognosis of visual outcome after visual loss from giant cell arteritis. Ophthalmology 2005; 112: 1098–103.Google Scholar PubMed

Dasgupta, B, Borg, FA, Hassan, N, et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford) 2010; 49: 1594–7.Google Scholar PubMed

Davies, CG, May, DJ. The role of temporal artery biopsies in giant cell arteritis. Ann R Coll Surg Engl 2011; 93: 4–5.10.1308/003588411X12851639107476CrossRef Google Scholar PubMed

Dejaco, C, Singh, YP, Perel, P, et al. Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: A systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica. Ann Rheum Dis 2015; 74: 1808–17.Google Scholar PubMed

Gilden, D, White, T, Khmeleva, N, et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology 2015; 84: 1948–55.CrossRef Google Scholar PubMed

Gonzalez‐Gay, MA, Vazquez‐Rodriguez, TR, Lopez‐Diaz, MJ, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Care Res 2009; 61: 1454–61.10.1002/art.24459CrossRef Google Scholar PubMed

Gonzalez-Gay, MA, Vazquez-Rodriguez, TR, Gomez-Acebo, I, et al. Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis. Medicine (Baltimore) 2009; 88: 227–35.10.1097/MD.0b013e3181af4518CrossRef Google Scholar

Hayreh, SS. Posterior ischaemic optic neuropathy: Clinical features, pathogenesis, and management. Eye (Lond) 2004; 18: 1188–206.10.1038/sj.eye.6701562CrossRef Google Scholar

Hayreh, SS, Zimmerman, MB. Amaurosis fugax in ocular vascular occlusive disorders: Prevalence and pathogeneses. Retina 2014; 34: 115–22.10.1097/IAE.0b013e31829234b5CrossRef Google Scholar PubMed

Hayreh, SS, Zimmerman, B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology 2003; 110: 1204–15.CrossRef Google Scholar PubMed

Hayreh, SS, Zimmerman, B, Kardon, RH. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature. Acta Ophthalmol Scand 2002; 80: 355–67.10.1034/j.1600-0420.2002.800403.xCrossRef Google Scholar PubMed

Hayreh, SS, Podhajsky, PA, Zimmerman, B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998a; 125: 509–20.Google Scholar PubMed

Hayreh, SS, Podhajsky, PA, Zimmerman, B. Occult giant cell arteritis: Ocular manifestations. Am J Ophthalmol 1998b; 125: 521–6.Google Scholar PubMed

Hayreh, SS, Podhajsky, PA, Raman, R, Zimmerman, B. Giant cell arteritis: Validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997; 123: 285–96.10.1016/S0002-9394(14)70123-0CrossRef Google Scholar PubMed

Horton, B, Magath, T, Brown, G. An undescribed form of arteritis of the temporal vessels. Mayo Clin Proc 1932; 7: 700–1.Google Scholar

Hunder, GG, Sheps, SG, Allen, GL, Joyce, JW. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: Comparison in a prospective study. Ann Intern Med 1975; 82: 613–8.CrossRef Google Scholar PubMed

Hunder, GG, Bloch, DA, Michel, BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122–8.Google Scholar PubMed

Hutchinson, J. Diseases of the arteries. On a peculiar form of thrombotic arteritis of the aged which is sometimes productive of gangrene. Arch Surg 1890; 1: 323–9.Google Scholar

Hunder, GG. The use and misuse of classification and diagnostic criteria for complex diseases. Ann Intern Med 1998; 129: 417–8.10.7326/0003-4819-129-5-199809010-00013CrossRef Google Scholar PubMed

Kermani, TA, Warrington, KJ, Crowson, CS, et al. Large-vessel involvement in giant cell arteritis: A population-based cohort study of the incidence – trends and prognosis. Ann Rheum Dis 2013; 72: 1989–94.10.1136/annrheumdis-2012-202408CrossRef Google Scholar PubMed

Kermani, TA, Schmidt, J, Crowson, CS, et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 2012; 41: 866–71.10.1016/j.semarthrit.2011.10.005CrossRef Google Scholar PubMed

Khan, A, Dasgupta, B. Imaging in giant cell arteritis. Curr Rheumatol Rep 2015; 17: 52, 015–0527-y.10.1007/s11926-015-0527-yCrossRef Google Scholar PubMed

Lariviere, D, Sacre, K, Klein, I, et al. Extra- and intracranial cerebral vasculitis in giant cell arteritis: An observational study. Medicine (Baltimore) 2014; 93: e265.10.1097/MD.0000000000000265CrossRef Google Scholar PubMed

Mahr, AD, Jover, JA, Spiera, RF, et al. Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis. Arthritis Rheum 2007; 56: 2789–97.10.1002/art.22754CrossRef Google Scholar PubMed

Ma-Krupa, W, Jeon, MS, Spoerl, S, et al. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 2004; 199: 173–83.CrossRef Google Scholar PubMed

Mclean, CA, Gonzales, MF, Dowling, JP. Systemic giant cell arteritis and cerebellar infarction. Stroke 1993; 24: 899–902.10.1161/01.STR.24.6.899CrossRef Google Scholar PubMed

Mohammad, AJ, Nilsson, JA, Jacobsson, LT, Merkel, PA, Turesson, C. Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden. Ann Rheum Dis 2015; 74: 993–7.10.1136/annrheumdis-2013-204652CrossRef Google Scholar PubMed

Mukhtyar, C, Guillevin, L, Cid, MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009; 68: 318–23.Google Scholar PubMed

Muratore, F, Pipitone, N, Hunder, GG, Salvarani, C. Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis. Clin Exp Rheumatol 2013; 31: S86–92.Google Scholar PubMed

Murchison, AP, Gilbert, ME, Bilyk, JR, et al. Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis. Am J Ophthalmol 2012; 154: 722–9.10.1016/j.ajo.2012.03.045CrossRef Google Scholar PubMed

Nagel, MA, White, T, Khmeleva, N, et al. Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis. JAMA Neurol 2015; 72: 1281–7.CrossRef Google Scholar PubMed

Narvaez, J, Bernad, B, Gomez-Vaquero, C, et al. Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis. Clin Exp Rheumatol 2008; 26: S57–62.Google Scholar PubMed

Narvaez, J, Bernad, B, Roig-Vilaseca, D, et al. Influence of previous corticosteroid therapy on temporal artery biopsy yield in giant cell arteritis. Semin Arthritis Rheum 2007; 37: 13–9.10.1016/j.semarthrit.2006.12.005CrossRef Google Scholar

Nesher, G, Berkun, Y, Mates, M, et al. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004; 50: 1332–7.10.1002/art.20171CrossRef Google Scholar PubMed

Parikh, M, Miller, NR, Lee, AG, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 2006; 113: 1842–5.10.1016/j.ophtha.2006.05.020CrossRef Google Scholar PubMed

Pego-Reigosa, R, Garcia-Porrua, C, Pineiro, A, et al. Predictors of cerebrovascular accidents in giant cell arteritis in a defined population. Clin Exp Rheumatol 2004; 22: S13–7.Google Scholar

Prieto-Gonzalez, S, Arguis, P, Garcia-Martinez, A, et al. Large vessel involvement in biopsy-proven giant cell arteritis: Prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 2012; 71: 1170–6.CrossRef Google Scholar PubMed

Salvarani, C, Pipitone, N, Versari, A, Hunder, GG. Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol 2012; 8: 509–21.10.1038/nrrheum.2012.97CrossRef Google Scholar PubMed

Samson, M, Jacquin, A, Audia, S, et al. Stroke associated with giant cell arteritis: A population-based study. J Neurol Neurosurg Psychiatry 2015; 86: 216–21.CrossRef Google Scholar PubMed

Save-Soderbergh, J, Malmvall, BE, Andersson, R, Bengtsson, BA. Giant cell arteritis as a cause of death. Report of nine cases. JAMA 1986; 255: 493–6.CrossRef Google Scholar PubMed

Smith, JH, Swanson, JW. Giant cell arteritis. Headache 2014; 54: 1273–89.10.1111/head.12425CrossRef Google Scholar PubMed

Solomon, CG, Weyand, CM, Goronzy, JJ. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 2014; 371: 50–7.Google Scholar

Soussan, M, Nicolas, P, Schramm, C, et al. Management of large-vessel vasculitis with FDG-PET: A systematic literature review and meta-analysis. Medicine (Baltimore) 2015; 94: e622.10.1097/MD.0000000000000622CrossRef Google Scholar PubMed

Stacy, RC, Rizzo, JF, Cestari, DM. Subtleties in the histopathology of giant cell arteritis. Semin Ophthalmol 2011; 26: 342–8.10.3109/08820538.2011.588656CrossRef Google Scholar PubMed

Stone, JH, Tuckwell, K, Dimonaco, S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med 2017; 377: 317–28.CrossRef Google Scholar PubMed

Tomasson, G, Peloquin, C, Mohammad, A, et al. Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: A cohort study. Ann Intern Med 2014a; 160: 73–80.10.7326/M12-3046CrossRef Google Scholar PubMed

Tomasson, G, Peloquin, C, Mohammad, A, et al. Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: A cohort study. Ann Intern Med 2014b; 160: 73–80.10.7326/M12-3046CrossRef Google Scholar PubMed

Ungprasert, P, Thongprayoon, C, Kittanamongkolchai, W, Srivali, N, Cheungpasitporn, W. Peripheral arterial disease in patients with giant cell arteritis: A meta-analysis. Int J Rheum Dis 2016; 19: 819–25.CrossRef Google Scholar PubMed

Weyand, CM, Hicok, KC, Hunder, GG, Goronzy, JJ. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest 1992; 90: 2355–61.10.1172/JCI116125CrossRef Google Scholar

Weyand, CM, Liao, YJ, Goronzy, JJ. The immunopathology of giant cell arteritis: Diagnostic and therapeutic implications. J Neuroophthalmol 2012; 32: 259–65.10.1097/WNO.0b013e318268aa9bCrossRef Google Scholar PubMed

Wilkinson, IM, Russell, RW. Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. Arch Neurol 1972; 27: 378–91.10.1001/archneur.1972.00490170010003CrossRef Google Scholar PubMed

Yates, M, Loke, YK, Watts, RA, MacGregor, AJ. Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: Meta-analysis. Clin Rheumatol 2014; 33: 227–36.10.1007/s10067-013-2384-2CrossRef Google Scholar

Zenone, T. Fever of unknown origin in rheumatic diseases. Infect Dis Clin North Am 2007; 21: 1115, 35, x–xi.10.1016/j.idc.2007.08.006CrossRef Google Scholar PubMed

References

Al-Homood, I. A. (2014). Tocilizumab: A new therapy for large vessel vasculitis. Clinical and Experimental Medicine, 14, 355.10.1007/s10238-013-0254-5CrossRef Google Scholar PubMed

Asaoka, K., Houkin, K., Fujimoto, S., Ishikwa, T., & Abe, H. (1998). Intracranial aneurysmas associated with aortitis syndrome: Case report and review of the literature. Neurosurgery, 42, 157.CrossRef Google Scholar

Ask-Upmark, E. & Fajers, C.-M. (1956). Further observations on Takayasu’s syndrome. Acta Medica Scandinavica, 155, 275.CrossRef Google Scholar

Bleck, T. P. (1989). Takayasu’s disease. In Handbook of Clinical Neurology, ed. Toole, J.F.. Chicago: Elsevier, vol. 11: part III, ch. 20.Google Scholar

Bustamante, R. A., Milanes, B., Casas, M., & De-La Torre, A. (1954). The chronic subclavian-carotid obstruction syndrome (pulseless disease). Angiology, 5, 479.10.1177/000331975400500604CrossRef Google Scholar PubMed

Caltran, E., Di Colo, G., Ghigliotti, G., et al. (2014). Two Takayasu arteritis patients successfully treated with rituximab. Clin Rheumat, 33, 1183.10.1007/s10067-014-2506-5CrossRef Google Scholar PubMed

Davy, J. (1839). Researches, Physiological and Anatomical, Volume 1, London: Smith Elder and Co. (quoted from Judge et al., 1962).Google Scholar

de Souza, A. W. S., Machado, N. P., Pereira, V. M., et al. (2010). Antiplatelets therapy for the prevention of arterial ischemic events in Takayasu arteritis. Circulation Journal, 74, 1236.10.1253/circj.CJ-09-0905CrossRef Google Scholar PubMed

Deyu, Z., Dijun, F., & Lisheng, L. (1992). Takayasu arteritis in China: A report of 530 cases. Heart Vessels, Suppl 7, 32.10.1007/BF01744541CrossRef Google Scholar

Dong, R.-P., Kimura, A., Numano, F., et al. (1992). HLA-DP antigen and Takayasu arteritis. Tissue Antigens, 39, 106.10.1111/j.1399-0039.1992.tb01918.xCrossRef Google Scholar PubMed

Frøvig, A. G. (1946). Bilateral obliteration of the common caroid artery. Thrombangitis obliterans? Acta Phychiatrica Neurologica Scandinavica, Suppl, 39.Google Scholar

Gibbons, T. B. & King, R. L. (1957). Obliterative brachiocephalic arteritis: Pulseless disease of Takayasu. Circulation, 15, 845.10.1161/01.CIR.15.6.845CrossRef Google Scholar PubMed

Giffin, H. M. (1939). Reversed coarctation and vasomotor gradient: Report of a cardiovascular anomaly with sympotoms of brain tumor. Proceedings of the Mayo Clinic, 14, 561.Google Scholar

Gilmour, J. R. (1941). Giant-cell arteritis. Journal of Pathology and Bacteriology, 53, 263.10.1002/path.1700530210CrossRef Google Scholar

Grosset, D. G., Patterson, J., & Bone, I. (1992). Intracranial haemodynamics in Takayasu’s arteritis. Acta Neurochirurgica, 119, 161.10.1007/BF01541802CrossRef Google Scholar PubMed

Hall, S., Barr, W., Lie, J. T., et al. (1985). Takayasu arteritis. Medicine, 94, 89.10.1097/00005792-198503000-00002CrossRef Google Scholar

Hata, A., Noda, M., Moriwaki, R., & Numano, F. (1996). Angiographic findings of Takayasu arteritis: New classification. International Journal of Cardiology, 54 (Suppl), s155.CrossRef Google Scholar PubMed

Hirose, K. & Baba, K. (1963). A study of fundus changes in the early stages of Takayasu–Ohnishi (pulseless) disease. American Journal of Ophthalmology, 55, 293.Google Scholar PubMed

Hirsch, M. S., Aikat, B. K., & Basu, A. K. (1964). Takayasu arteritis. Bulletin Johns Hopkins Hospital, 115, 29.Google Scholar

Ishikawa, K. (1981). Survival and morbidity after diagnosis of occlusive thromboaortopathy (Takayasu’s disease). American Journal of Cardiology, 47, 1026.10.1016/0002-9149(81)90208-3CrossRef Google Scholar PubMed

Ito, I. (1995). Aortitis syndrome (Takayasu’s arteritis). A historical perspective. Japan Heart Journal, 36, 273.Google Scholar PubMed

Judge, R. D., Currier, R. D., Gracie, W. A., & Figley, M. M. (1962). Takayasu’s arteritis and the aortic arch syndrome. American Journal of Medicine, 32, 379.10.1016/0002-9343(62)90128-6CrossRef Google Scholar PubMed

Kalmanson, R. B. & Kalmansohn, R. W. (1957). Thrombotic obliteration of the branches of the aortic arch. Circulation, 15, 237.10.1161/01.CIR.15.2.237CrossRef Google Scholar

Kerr, G. S., Hallahan, C. W., Gierdant, J., et al. (1994). Takayasu arteritis. Annals of Internal Medicine, 120, 919.10.7326/0003-4819-120-11-199406010-00004CrossRef Google Scholar PubMed

Kissin, E. Y. & Merkel, P. A. (2004). Diagnostic imaging in Takayasu arteritis. Current Opinion in Rheumatology, 16, 31.10.1097/00002281-200401000-00007CrossRef Google Scholar PubMed

Koide, K. (1992). Aortitis syndrome. Nihon Rinsho, 50 (Supplement), 343 (in Japanese).Google Scholar PubMed

Koszewski, B. J. (1958). Branchial arteritis or aortic arch arteritis. A new inflammatory arterial disease (pulseless disease). Angiology, 9, 180.10.1177/000331975800900307CrossRef Google Scholar PubMed

Kussmaul, A. (1873). Zwei Falle von spontaner allmaliger Verschliessung grosser Halsarterienstamme. Deutsche Klinik, 24, 461.Google Scholar

Lessoff, M. H. & Glynn, L. E. (1959). Pulseless syndrome. Lancet, 8, 799–847.10.1016/S0140-6736(59)91993-2CrossRef Google Scholar

Lupi-Herrera, E., Sanchez-Torres, G., Marcushamer, J., et al. (1979). Takayasu’s arteritis. Clinical study of 107 cases. American Heart Journal, 73, 94.Google Scholar

Marquis, J., Richardson, J. B., Ritchie, A. C., & Wigle, E. D. (1968). Idiopathic medial aortopathy and arteriopathy. American Journal of Medicine, 44, 939.10.1016/0002-9343(68)90094-6CrossRef Google Scholar PubMed

Martorell, F. & Fabbé Tersol, J. (1944). El síndrome de obliteración de los troncos supraaorticos. Medicina Clínica (Barcelona), 2, 26.Google Scholar

Moriwaki, R., Noda, M., Yajima, M., Sharma, B. K., & Numano, F. (1997). Clinical manifestations of Takayasu arteritis in India and Japan: New classification of angiographic findings. Angiology, 48, 369.CrossRef Google Scholar PubMed

Miyata, T. (2014). The Asia Pacific meeting for vasculitis and ANCA workshop 2012: Surgical treatment for Takayasu’s arteritis. Clinical and Experimental Nephrology, 18, 296.10.1007/s10157-013-0894-5CrossRef Google Scholar

Nakao, K., Ikeda, M., Kimata, S., et al. (1967). Takayasu’s arteritis. Clinical report of eighty-four cases and immunologic studies of seven cases. Circulation, 35, 1141.10.1161/01.CIR.35.6.1141CrossRef Google Scholar PubMed

Nakaoka, Y., Higuchi, K., Arita, Y., et al. (2013). Tocilizumab for the treatment of patients with refractory Takayasu arteritis. International Heart Journal, 54, 405.10.1536/ihj.54.405CrossRef Google Scholar PubMed

Nastri, M. V., Baptista, L. P. S., Baroni, R. H., et al. (2004). Gadolinium-enhanced three-dimensional MR angiography of Takayasu arteritis. Radio Graphics, 24, 773.Google Scholar PubMed

Ohigashi, H., Haraguchi, G., Konishi, M., et al. (2014). Improved prognosis of Takayasu arteritis over the past decade: Comprehensive analysis of 106 patients. Circulation Journal, 76, 1004.10.1253/circj.CJ-11-1108CrossRef Google Scholar

Osman, M., Emery, D., & Yacyshyn, E. (2015). Tocilizumab for treating Takayasu’s arteritis and associated stroke: A case series and updated review of the literature. Journal of Stroke and Cerebrovascular Diseases, 24, 1291.CrossRef Google Scholar PubMed

Pahwa, J. M., Pandey, M. P., & Gypha, D. P. (1959). Pulseless disease, or Takayasu’s disease. British Medical Journal, 2, 1439.10.1136/bmj.2.5164.1439CrossRef Google Scholar PubMed

Pokrovsky, A. V., Tsereshkin, D. M., & Golossovskaya, M. A. (1980). Pathology of non-specific aortoarteritis. Angiology, 31, 549.10.1177/000331978003100807CrossRef Google Scholar

Reivich, M., Holling, H. E., Roberts, B., & Toole, J. F. (1961). Reversal of blood flow through the vertebral artery and its effects on cerebral circulation. New England Journal of Medicine, 265, 878.10.1056/NEJM196111022651804CrossRef Google Scholar PubMed

Rose, A. G. & Sinclair-Smith, C. C. (1980). Takayasu’s arteritis: A study of 16 autopsy cases. Archives of Pathology and Laboratory Medicine, 104, 231.Google Scholar PubMed

Ross, R. S. & McKusick, V. A. (1953). Aortic arch syndromes. Diminished or absent pulses in arteries arising from arch of aorta. Archives of Internal Medicine, 92, 701.Google Scholar PubMed

Sato, T., Kunimatsu, J., Maeda, J., et al. (2014). Diagnosis of late-onset Takayasu arteritis for elderly adults using fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. JAGS, 62, 2463.10.1111/jgs.13151CrossRef Google Scholar PubMed

Savory, W. S. (1856). Case of a young woman in whom the main arteries of both upper extremities and of the left side of the neck were throughout completely obliterated. Transactions Medical-Chirurgical Society (London), London, 39, 205, (quoted from Judge et al., 1962).Google Scholar

Sharma, S., Saxena, A., Talwar, K. K., et al. (1992). Renal artery stenosis caused by nonspecific arteritis (Takayasu disease): Results of treatment with percutaneous transluminal angioplasty. American Journal of Radiology, 158, 417.Google Scholar PubMed

Shimizu, K. & Sano, K. (1951). Pulseless disease. Journal of Neuropathology and Experimental Neurology, 1, 37.Google Scholar PubMed

Stanley, P., Roebuck, D., & Barboza, A. (2003). Takayasu’s arteritis in children. Techniques in Vascular and Interventional Radiology, 6, 158.10.1053/j.tvir.2003.10.002CrossRef Google Scholar PubMed

Tabata, M., Kitagawa, T., Saito, T., et al. (2001). Extracranial carotid aneurysm in Takayasu’s arteritis. Journal of Vascular Surgery, 34, 739.CrossRef Google Scholar PubMed

Takano, K., Sadoshima, S., Ibayashi, S., Ichiya, Y., & Fujishima, M. (1993). Altered cerebral hemodynamics and metabolism in Takayasu’s arteritis with neurological deficits. Stroke, 24, 1501.CrossRef Google Scholar PubMed

Takayasu, M. (1908). A case with peculiar changes of the central retinal vessels. Acta Societatis Ophthalmologicae Japonicae, 12, 554, (in Japanese).Google Scholar

Tachibana, M., Mukouhara, N., Hirami, R., et al. (2014). Ultrasonography is convenient and useful for assessment and follow-up of Takayasu’s arteritis. Journal of Medical Ultrasonics, 41, 365.10.1007/s10396-013-0515-7CrossRef Google Scholar PubMed

Terao, C. (2014). History of Takayasu arteritis and Dr. Mikito Takayasu. International Journal of Rheumatic Diseases, 17, 2014.10.1111/1756-185X.12576CrossRef Google Scholar PubMed

Thurlbeck, W. M. & Currens, J. H. (1959). The aortic arch syndrome (pulseless disease): A report of ten cases with three autopsies. Circulation, 19, 499.10.1161/01.CIR.19.4.499CrossRef Google Scholar PubMed

Uchida, Y., Matsukawa, N., Oguri, T., et al. (2011). Reversible cerebral vasoconstriction syndrome in a patient with Takayasu’s arteritis. Internal Medicine, 50, 1611.10.2169/internalmedicine.50.5185CrossRef Google Scholar

Watanabe, Y., Miyata, T., & Tanemoto, K. (2015). Current clinical features of new patients with Takayasu arteritis observed from cross-country research in Japan: Age and sex specificity. Circulation, 132, 1701.10.1161/CIRCULATIONAHA.114.012547CrossRef Google Scholar PubMed

Yamanaka, T., Sawai, Y., & Hosoi, H. (2013). Bilateral subclavian steal syndrome with vertigo. Auris Nasus Larynx, 41, 307.10.1016/j.anl.2013.08.004CrossRef Google Scholar PubMed

Yang, L., Zhang, H., Jiang, X., et al. (2015). Clinical features and outcomes of Takayasu arteritis with neurological symptoms in China: A retrospective study. Journal of Rheumatology, 42, 1846.CrossRef Google Scholar

References

Akman-Demir, G., Baykan-Kurt, B., Serdaroglu, P., et al. 1996. Seven-year followup of neurologic involvement in Behçet’s syndrome. Arch Neurol, 53, 691–4.10.1001/archneur.1996.00550070133022CrossRef Google Scholar

Akman-Demir, G., Bahar, S., Çoban, O., et al. 1998. Cranial MRI findings in Behçet’s disease: A study of 134 MRI of 98 cases. J Neurol, 245, 362.Google Scholar

Allen, N. B. 1993. Miscellaneous vasculitic syndromes including Behçet’s disease and central nervous system vasculitis. Curr Opin Rheumatol, 5, 51–6.10.1097/00002281-199305010-00008CrossRef Google Scholar PubMed

Ameri, A. and Bousser, M. G. 1992. Cerebral venous thrombosis. Neurol Clin, 10, 87–111.10.1016/S0733-8619(18)30235-4CrossRef Google Scholar PubMed

Arias, M. J., Calero, E., Gil, J. F., and Paz, J. 1987. Spinal subarachnoid hematoma in Behçet’s disease. Neurosurgery, 20, 62–3.10.1097/00006123-198701000-00016CrossRef Google Scholar PubMed

Arida, A. and Sfikakis, P.P. 2014. Anti-cytokine biologic treatment beyond anti-TNF in Behçet’s disease. Clin Exp Rheumatol, 32 (Suppl. 84), S149–55.Google Scholar PubMed

Assaad-Khalil, S., Abou-Seif, M., Abou-Seif, S., El-Sewy, F., and El-Sewy, M. 1993. Neurologic involvement in Behçet’s disease: Clinical, genetic and computed tomographic study. In Wechsler, B. and Godeau, P., eds., Behçet’s Disease. Amsterdam: Excerpta Medica International Congress Series, 1037, pp.409–14.Google Scholar

Bahar, S., Çoban, O., Gürvit, I. H., Akman-Demir, G., and Gökyiğit, A. 1993. Spontaneous dissection of the extracranial vertebral artery with spinal subarachnoid haemorrhage in a patient with Behçet’s disease. Neuroradiology, 35, 352–4.10.1007/BF00588368CrossRef Google Scholar

Banna, M. and El Ramahi, K. 1991. Neurologic involvement in Behçet’s disease: Imaging findings in 16 patients. Am J Neuroradiol, 12, 791–6.Google Scholar PubMed

Bartlett, S. T., McCarthy, W. J. III, Palmer, A. S., et al. 1988. Multiple aneurysms in Behçet’s disease. Arch Surg, 123, 1004–8.10.1001/archsurg.1988.01400320090018CrossRef Google Scholar PubMed

Behçet, H. 1937. Ueber rezidivierende Aphtöse durch ein Virus verursachte Geschwüre am Mund am Auge und an den Genitalen. Dermatol Wochensch 36, 1152–7.Google Scholar

Ben-Itzhak, J., Keren, S., and Simon, J. 1985. Intracranial venous thrombosis in Behçet’s syndrome. Neuroradiology, 27, 450–1.10.1007/BF00327616CrossRef Google Scholar PubMed

Benamour, S., Zeroual, B., Bennis, R., Amraoui, A., and Bettal, S. 1990. Maladie de Behçet: 316 cas. Presse Med, 19, 1485–9.Google Scholar

Bienenstock, H. and Murray, E. M. 1961. Behçet’s syndrome: Report of a case with extensive neurologic manifestations. N Engl J Med, 264, 1342–5.10.1056/NEJM196106292642605CrossRef Google Scholar

Bousser, M. G., Bletry, O., Launay, M., et al. 1980. Thromboses veineuses céérébrales au cours de la maladie de Behçet. Revue Neurologique, 136, 753–62.Google Scholar

Bousser, M. G., Chiars, J., and Bories, J. 1985. Cerebral venous thrombosis: A review of 38 cases. Stroke, 16, 199–211.CrossRef Google Scholar PubMed

Buge, A., Vincent, D., Rancurel, G., et al. 1987. Maladie de Behçet avec anévrysmes artériels multiples intracraniens. Revue Neurologique, 143, 832–5.Google Scholar

Cavara, V., and D’Ermo, F. 1954. A case of Behçet’s syndrome. XVII Concilium. Acta Ophthalmol (Copenh), 3, 1489–505.Google Scholar

Çoban, O., Bahar, S., Akman-Demir, G., et al. 1999. Masked assessment of MRI findings: Is it possible to differentiate neuro-Behçet’s disease from other central nervous system diseases? Neuroradiology, 41, 255–60.Google Scholar PubMed

Davitchi, F., Shavran, F., Akbarin, M., et al. 1997. Behçet’s disease: Analysis of 3443 cases. APLAR J Rheumatol, 1, 2–5.Google Scholar

Dilsen, N. 2000. About diagnostic criteria for Behçet’s disease: Our new proposal. In Bang, D., Lee, E. S., Lee, S., eds., Behçet’s Disease. Seoul: Design Mecca Publishing Co., pp. 101–4.Google Scholar

Ehrlich, G. E. 1997. Vasculitis in Behçet’s disease. Int Rev Immunol, 14, 81–8.10.3109/08830189709116846CrossRef Google Scholar PubMed

Emmi, L., Salvati, G., Brugnolo, F., and Morchione, T. 1995. Immunopathological aspects of Behçet’s disease. Clin Exp Rheumatol, 13, 687–91.Google Scholar PubMed

Emmungil, H., Yaşar Bilge, N.Ş., Küçükşahin, O., et al. 2014. A rare but serious manifestation of Behçet’s disease: Intracardiac thrombus in 22 patients. Clin Exp Rheumatol, 32 (Suppl. 84), 87–92.Google Scholar PubMed

Fusegawa, H., Ichikawa, Y., Tanaka, Y., et al. 1991. Blood coagulation and fibrinolysis in patients with Behçet’s disease. Rinsho Byori, 39, 509–16.Google Scholar PubMed

Gerber, S., Biondi, A., Dormont, D., Wechsler, B., and Marsault, C. 1996. Longterm MR follow-up of cerebral lesions in neuro-Behçet’s disease. Neuroradiology, 38, 761–8.10.1007/s002340050343CrossRef Google Scholar PubMed

Godeau, P., Wechsler, B., Maaouni, A., Fagard, M., and Herreman, G. 1980. Manifestations cardiovasculaires de la maladie de Behçet. Ann Dermatol et Vénéréol, 167, 741–7.Google Scholar

Hadfield, M. G., Aydin, F., Lippman, H. R., and Sanders, K. M. 1997. Neuro-Behçet’s disease [Review]. Clin Neuropathol, 16, 55–60.Google Scholar PubMed

Hampton, K. K., Chamberlain, M. A., Menon, D. K., and Davies, J. A. 1991. Coagulation and fibrinolytic activity in Behçet’s disease. Thromb Haemost, 66, 292–4.Google Scholar PubMed

Harper, M. C., O’Neill, B. P., O’Duffy, J. D., and Forbes, G. S. 1985. Intracranial hypertension in Behçet’s disease: Demonstration of sinus occlusion with use of digital subtraction angiography. Mayo Clin Proc, 60, 419–22.10.1016/S0025-6196(12)60853-2CrossRef Google Scholar PubMed

Hassen Khoda, R., Declemy, S., Batt, M., et al. 1991. Maladie de Behçet avec atteinte artérielle multiple et volumineux angiome intra-cérébrale. Journal des Maladies Vasculaires, 16, 383–6.Google Scholar

Hatemi, G., Seyahi, E., Fresko, I., Talarico, R., and Hamuryudan, V. 2014. Behçet’s syndrome: A critical digest of the 2013–2014 literature. Clin Exp Rheumatol, 32 (Suppl. 84): S112–22.Google Scholar PubMed

Herskovitz, S., Lipton, R. B., and Lantos, G. 1988. Neuro-Behçet’s disease. CT and clinical correlates. Neurology, 38, 1714–20.10.1212/WNL.38.11.1714CrossRef Google Scholar PubMed

Huong du, L. T., Wechsler, B., Piette, J. C., et al., 1993. Long term prognosis of arterial lesions in Behçet’s disease. In Wechsler, B. and Godeau, P., eds., Behçet’s Disease. Amsterdam: Excerpta Medica, pp. 557–62.Google Scholar

Imaizumi, M., Nukada, T., Toneda, S., and Abe, H. 1980. Behçet’s disease with sinus thrombosis and arteriovenous malformation in brain. J Neurol, 222, 215–8.10.1007/BF00313120CrossRef Google Scholar PubMed

International Study Group for Behçet’s Disease. 1990. Criteria for Behçet’s disease. Lancet, 335, 1078–80.Google Scholar

Iragui, V. J. and Maravi, E. 1986. Behçet’s syndrome presenting as cerebrovascular disease. J Neurol Neurosurg Psychiatr, 49, 838–40.10.1136/jnnp.49.7.838CrossRef Google Scholar PubMed

Kawakita, H., Nishimura, N., Satoh, Y., and Shibata, N. 1967. Neurological aspects of Behçet’s disease. J Neurol Sci, 5, 417–39.10.1016/0022-510X(67)90083-4CrossRef Google Scholar PubMed

Kidd, D., Steuer, A., Denman, M., and Rudge, P. 1999. Neurological complications in Behçet’s syndrome. Brain, 122, 2183–94.10.1093/brain/122.11.2183CrossRef Google Scholar PubMed

Kikuchi, H., Takayama, M., and Hirohata, S. 2014. Quantitative analysis of brainstem atrophy on magnetic resonance imaging in chronic progressive neuro-Behçet’s disease. J Neurol Sci, 337, 80–5.10.1016/j.jns.2013.11.020CrossRef Google Scholar PubMed

Knapp, P. 1941. Beitrag zur Symptomatologie und Therapie der rezidivierenden Hypopyoniritis und der begleitenden aphtözen Schleimhauterkrankungen. Schweiz Med Wochenschr, 71, 1288–90.Google Scholar

Krespi, Y., Akman-Demir, G., Poyraz, M., et al. 2001. Cerebral vasculitis and ischaemic stroke in Behçet’s disease: Report of one case and review of the literature. Eur J Neurol, 8, 719–22.10.1046/j.1468-1331.2001.00300.xCrossRef Google Scholar PubMed

Kumral, E., Evyapan, D., Oksel, F., Keser, G., and Bereketoglu, M. A. 1999. Transcranial Doppler detection of MES in patients with Behçet’s disease. J Neurol, 246, 592–5.10.1007/s004150050409CrossRef Google Scholar PubMed

Kumral, E., Evyapan, D., Tunçel, R. 2012. Reversible cerebral venulitis in a patient with neuro-Behçet’s disease. Eur J Neurol, 19:e75–6.10.1111/j.1468-1331.2012.03738.xCrossRef Google Scholar

Lakhanpal, S., Tani, K., Lie, J. T., et al. 1985. Pathologic features of Behçet’s syndrome: A review of Japanese autopsy registry data. Hum Pathol, 16, 790–5.10.1016/S0046-8177(85)80250-1CrossRef Google Scholar PubMed

Lehner, T. 1997. The role of heat shock protein, microbial and autoimmune agents with the aetiology of Behçet’s disease. Int Rev Immunol, 14, 21–32.10.3109/08830189709116842CrossRef Google Scholar PubMed

Lehner, T., Lavery, R., Smith, R., et al. 1991. Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet’s syndrome. Infect Immun, 59, 1434–41.10.1128/iai.59.4.1434-1441.1991CrossRef Google Scholar PubMed

Macchi, P., Grossman, R. I., Gomori, J. M., et al. 1986. High field MR imaging of cerebral venous thrombosis. J Comput Assist Tomogr, 10, 10–5.10.1097/00004728-198601000-00002CrossRef Google Scholar

Masheter, H. C. 1959. Behçet’s syndrome complicated by intracranial thrombophlebitis. Proc R Soc Med, 52, 1039–40.Google Scholar PubMed

Matsumoto, T., Uekusa, T., and Fukuda, Y. 1991. Vasculo-Behçet’s disease: A pathologic study of eight cases. Hum Pathol, 22, 45–51.10.1016/0046-8177(91)90060-3CrossRef Google Scholar PubMed

Medejel, A., El Alaoui Faris, M., Al-Zemmouri, K., et al. 1986. Les manifestations neurologiques de la maladie de Behçet. Semaine des Hôpitaux, 62, 1325–8.Google Scholar

Miller, D. H., Ormerod, I. E., Gibson, A., et al. 1987. MR brain scanning in patients with vasculitis: Differentiation from multiple sclerosis. Neuroradiology, 29, 226–31.10.1007/BF00451758CrossRef Google Scholar PubMed

Mizuki, N., Meguro, A., Ota, M., et al. 2010. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet’s disease susceptibility loci. Nat Genet, 42: 703.10.1038/ng.624CrossRef Google Scholar PubMed

Montalban, J., Codina, A., Alijotas, J., Ordi, J., and Khamashta, M. 1990. Magnetic resonance imaging in Behçet’s disease. J Neurol Neurosurg Psychiatry, 53, 442.10.1136/jnnp.53.5.442CrossRef Google Scholar PubMed

Morissey, S. P., Miller, D. H., Hermaszewski, R., et al. 1993. Magnetic resonance imaging of the central nervous system in Behçet’s disease. Eur Neurol, 33, 287–93.10.1159/000116956CrossRef Google Scholar

Nagata, K. 1985. Recurrent intracranial haemorrhage in Behçet’s disease. J Neurol Neurosurg Psychiatr, 48, 190–1.10.1136/jnnp.48.2.190CrossRef Google Scholar

Nishimura, M., Satoh, K., Suga, M., and Oda, M. 1991. Cerebral angio- and neuro-Behçet’s syndrome: Neuroradiological and pathological study of one case. J Neurol Sci, 106, 19–24.10.1016/0022-510X(91)90188-DCrossRef Google Scholar PubMed

O’Duffy, J. D. 1990. Behçet’s syndrome. N Engl J Med, 322, 326–7.Google Scholar PubMed

O’Duffy, J. D. 1994. Behçet’s disease [Review]. Curr Opin Rheumatol, 6, 39–43.10.1097/00002281-199401000-00007CrossRef Google Scholar PubMed

O’Duffy, J. D. and Goldstein, N. P. 1976. Neurological involvement in seven patients with Behçet’s disease. Am J Med, 61, 170–8.Google Scholar PubMed

O’Duffy, J. D., Carney, J. A., and Deodhar, S. 1971. Behçet’s disease. Report of 10 cases, 3 with new manifestations. Ann Intern Med, 75, 561–9.Google Scholar PubMed

Ozyazgan, S., Uzun, H., Onal, B., Tuzcu, A., Ugurlu, S., Andican, G. 2013. Lectin-like oxidised LDL receptor-1 as a marker of endothelial dysfunction in Behçet’s disease. Clin Exp Rheumatol, 31 (Suppl. 77), 71–6.Google Scholar PubMed

Pamir, M. N., Kansu, T., Erbengi, A., and Zileli, T. 1981. Papilledema in Behçet’s syndrome. Arch Neurol, 38, 643–5.10.1001/archneur.1981.00510100071012CrossRef Google Scholar PubMed

Patel, D. V., Neuman, M. J., and Hier, D. B. 1989. Reversibility of CT and MR findings in neuro-Behçet’s disease. J Comput Assist Tomogr, 13, 669–73.10.1097/00004728-198907000-00022CrossRef Google Scholar

Pineton de Chambrun, M., Wechsler, B., Geri, G., Cacoub, P., and Saaddoun, D. 2012. New insights into the pathogenesis of Behçet’s disease. Autoimmun Rev, 11, 687–98.10.1016/j.autrev.2011.11.026CrossRef Google Scholar PubMed

Rougemont, D., Bousser, M. G., Wechsler, B., et al. 1982. Manifestations neurologiques de la maladie de Behçet. Revue Neurologique, 138, 493–505.Google Scholar

Rubinstein, L. J. and Urich, H. 1963. Meningo-encephalitis of Behçet’s disease: Case report with pathological findings. Brain, 86, 151–60.10.1093/brain/86.1.151CrossRef Google Scholar PubMed

Sakane, T. 1997. New perspective on Behçet’s disease [Review]. Int Rev Immunol, 14, 89–96.10.3109/08830189709116847CrossRef Google Scholar PubMed

Saruhan-Direskeneli, G., Akman-Demir, G., Tasçi, B., Serdaroglu, P., and Eraksoy, M. 1996. Local synthesis of oligoclonal IgG is infrequent in Behçet’s disease. Rev Rheumatol, 63 Suppl, 552.Google Scholar

Serdaroglu, P. 1998. Behçet’s disease and the nervous system. J Neurol, 245, 197–205.Google Scholar PubMed

Serdaroglu, P., Yazici, H., Özdemir, Ç., et al. 1989. Neurologic involvement in Behçet’s syndrome. A prospective study. Arch Neurol, 46, 265–9.10.1001/archneur.1989.00520390031011CrossRef Google Scholar PubMed

Shakir, R. A., Sulaiman, K., Kahn, R. A., and Rudwan, M. 1990. Neurological presentation of neuro-Behçet’s syndrome: Clinical categories. Eur Neurol, 30, 249–53.10.1159/000117356CrossRef Google Scholar PubMed

Farrell, Shapiro L. S., Borhani, J. Hag-Highi, A. 2012. Tocilizumab treatment for neuro-Behçet’s disease, the first report. Clin Neurol Neurosurg, 114: 297–8.Google Scholar

Shimizu, T. 1962. Epidemiological and clinico-pathological studies on neuro-Behçet’s syndrome. Adv Neurol Sci (Tokyo), 16, 167–78.Google Scholar

Shimizu, T., Ehrlich, G. E., Inaba, G., and Hayashi, K. 1979. Behçet’s disease. Semin Arthritis Rheum, 8, 223–60.10.1016/0049-0172(79)90004-0CrossRef Google Scholar

Stanford, M. R., Kasp, E., Whiston, R., et al. 1994. Heat shock protein peptides reactive in Behçet’s disease are uveitogenic in Lewis rats. Clin Exp Immunol, 97, 226–31.Google Scholar PubMed

Suga, M., Sato, K., Nishimura, M., and Oda, M. 1990. An autopsy case of neuro-Behçet’s disease with the middle cerebral artery occlusion on cerebral angiogram. Rinsho Shinkeigaku, 30, 1005–9.Google Scholar PubMed

Sugihara, H., Muto, Y., and Tsuchiyama, H. 1969. Neuro-Behçet’s syndrome: Report of two autopsy cases. Acta Pathology (Japan), 19, 95–101.Google Scholar PubMed

Suzuki, Y., Hoshi, K., Matsuda, T., and Mizushima, Y. 1992. Increased peripheral blood T cells and natural killer cells in Behçet’s disease. J Rheumatol, 19, 588–92.Google Scholar

Tasçi, B., Direskeneli, H., Serdaroglu, P., et al. 1998. Humoral immune response to mycobacterial heat shock protein (HSP) 65 in the cerebrospinal fluid of neuro-Behçet patients. Clin Exp Immunol, 113, 100–4.Google Scholar PubMed

Taşolar, S., Doğan, M., Taşolar, H., et al. 2014. Evaluation of vertebral artery involvement by Doppler sonography in patients with Behçet disease. J Ultrasound Med, 33: 811–6.10.7863/ultra.33.5.811CrossRef Google Scholar PubMed

Totsuka, S. and Midorikawa, T. 1972. Some clinical and pathological problems in neuro-Behçet’s syndrome. Folia Psychiatrica et Neurologica (Japan), 28, 275–84.Google Scholar

Totsuka, S., Hattori, T., and Yazari, M. 1979. Clinico-pathology of neuro-Behçet’s syndrome. In Kehner, T. and Barnes, C.G., eds., Behçet’s Disease. Clinical and Immunological Features. London: Academic Press, pp. 133–96.Google Scholar

Tsutsui, K., Hasegawa, M., Takata, M., and Takehara, K. 1998. Behçet’s disease. J Rheumatol, 25, 326–8.Google Scholar PubMed

Uruyama, A., Sakuragi, S., and Sakai, F. 1979. Angio-Behçet syndrome. In Lehner, T. and Barnes, C. G., eds., Behçet’s Syndrome. Clinical and Immunological Features. London: Academic Press, pp. 176–6.Google Scholar

Wechsler, B., Vidailhet, M., Piette, J. C., et al. 1992. Cerebral venous thrombosis in Behçet’s disease: Clinical study and long term follow-up of 25 cases. Neurology, 42, 614–8.10.1212/WNL.42.3.614CrossRef Google Scholar PubMed

Wechsler, B., Dell’Isola, B., Vidailhet, M., et al. 1993. Magnetic resonance imaging in 31 patients with Behçet disease and neurological involvement: Prospective study with clinical correlation. J Neurol Neurosurg Psychiatr, 56, 793–8.10.1136/jnnp.56.7.793CrossRef Google Scholar PubMed

Wilkins, M. R., Gove, R. I., Roberts, S. D., and Kendall, M. J. 1986. Behçet’s disease presenting as benign intracranial hypertension. Postgrad Med J, 62, 36–41.10.1136/pgmj.62.723.39CrossRef Google Scholar PubMed

Wolf, S. M., Scrotland, D. L., and Phillips, L. L. 1965. Involvement of nervous system in Behçet’s syndrome. Arch Neurol, 12, 315–25.10.1001/archneur.1965.00460270091012CrossRef Google Scholar PubMed

Yazici, H. 1997. The place of Behçet’s syndrome among the autoimmune diseases. Int Rev Immunol, 14, 1–10.10.3109/08830189709116840CrossRef Google Scholar PubMed

Yazici, H. 2002. Behçet’s syndrome: Where do we stand? Am J Med, 112, 75–6.10.1016/S0002-9343(01)01081-6CrossRef Google Scholar PubMed

Yazici, H., Tüzün, Y., Pazarlı, H., et al. 1980. The combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet’s disease in Turkey. J Rheumatol, 7, 206–10.Google Scholar PubMed

Yazici, H., and Moutsopoulos, H. H. 1985. Behçet’s disease. In Lichenstein, L. M. and Fauci, A. S., eds., Current Therapy in Allergy, Immunology and Rheumatology. Philadelphia: Decker, pp. 194–7.Google Scholar

Yazici, H., Basaran, E. G., Hamuryudan, V., et al. 1996. The ten-year mortality in Behçet’s syndrome. Br J Rheumatol, 35, 139–41.10.1093/rheumatology/35.2.139CrossRef Google Scholar PubMed

Zelenski, J. D., Caparo, J. A., Holden, D., and Calabrese, L. H. 1989. Central nervous system vasculitis in Behçet’s syndrome: Angiographic improvement after therapy with cytotoxic agents. Arthritis Rheum, 32, 217–20.10.1002/anr.1780320217CrossRef Google Scholar PubMed

References

Akova, Y. A., Kansu, T., and Duman, S. 1993. Pseudotumor cerebri secondary to dural sinus thrombosis in neurosarcoidosis. J Clin Neuroophthalmol, 13, 188–9.Google Scholar PubMed

Allen, R. K. A., Sellars, R. E., and Sandstrom, P. A. 2003. A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis, 20, 118–25.Google Scholar PubMed

Baughman, R. P. and Lower, E. E. 1997. Steroid-sparing alternative treatments for sarcoidosis. Clin Chest Med, 18, 853–64.10.1016/S0272-5231(05)70423-8CrossRef Google Scholar PubMed

Berek, K., Kiechl, S., Willeit, J., et al. 1993. Subarachnoid hemorrhage as presenting feature of isolated neurosarcoidosis. Clin Investig, 71, 54–6.10.1007/BF00210965CrossRef Google Scholar PubMed

Boeck, C. 1899. Multiple benign sarkoid of the skin. J Cutan Dis, 17, 543–50.Google Scholar

Brisman, J.L., Hinduja, A., McKinney, J.S., Gerhardstein, B. 2006. Successful emergent angioplasty of neurosarcoid vasculitis presenting with strokes. Surg Neurol, 66, 402–4.10.1016/j.surneu.2006.02.048CrossRef Google Scholar PubMed

Brown, M. M., Thompson, A. J., Wedzicha, J. A., and Swash, M. 1989. Sarcoidosis presenting with stroke. Stroke, 20, 400–5.10.1161/01.STR.20.3.400CrossRef Google Scholar PubMed

Burns, T. M. 2003. Neurosarcoidosis. Arch Neurol, 60, 1166–8.10.1001/archneur.60.8.1166CrossRef Google Scholar PubMed

Campbell, J., Kee, R., Bhattacharya, D., et al. 2015. Systemic sarcoidosis presenting with headache and stroke-like episodes. Case Reports Immunol, 2015, Article ID 619865.10.1155/2015/619867CrossRef Google Scholar PubMed

Caplan, L., Corbett, J., Goodwin, J., et al. 1983. Neuro-ophthalmologic signs in the angiitic form of neurosarcoidosis. Neurology, 33, 1130–5.10.1212/WNL.33.9.1130CrossRef Google Scholar PubMed

Corse, A. M. and Stern, B. J. 1989. Neurosarcoidosis and stroke. Stroke, 20, 152–3.Google Scholar

Dakdouki, G. K., Kanafani, Z. A., Ishak, G., Hourani, M., and Kanj, S. S. 2005. Intracerebral bleeding in a patient with neurosarcoidosis while on corticosteroid therapy. South Med J, 98, 492–4.10.1097/01.SMJ.0000146621.42198.31CrossRef Google Scholar

Degardin, A., Devos, P., Vermersch, P., and De Seze, J. 2010. Cerebrovascular symptomatic involvement in sarcoidosis. Acta Neurol Belg, 110, 349–352.Google Scholar PubMed

Gonzalez-Aramburu, I., Ruiz-Perez, E., Gomez-Roman, J., et al. 2012. Sarcoidosis presenting as transient ischemic attack status. J Stroke Cerebrovasc Dis, 21, 515–517.10.1016/j.jstrokecerebrovasdis.2010.12.003CrossRef Google Scholar PubMed

Hasday, J. D., Bachwich, P. R., Lynch, J. P., et al. 1988. Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis. Exp Lung Res, 14, 261–78.10.3109/01902148809115128CrossRef Google Scholar PubMed

Iannuzzi, M. C., Rybicki, B. A., and Teirstein, A. S. 2007. Sarcoidosis. New Engl J Med, 357, 2153–65.10.1056/NEJMra071714CrossRef Google Scholar PubMed

Kamphuis, L. S., Van Zelm, M. C., and Lam, K. H. 2013. Perigranuloma localization and abnormal maturation of B cells. Am J Respir Crit Care Med, 187, 406–16.10.1164/rccm.201206-1024OCCrossRef Google Scholar PubMed

Lareau, C. A., Adrianto, I., Levin, A. M., et al. 2015. Fine mapping of chromosome 15q25 implicates ZNF592 in neurosarcoidosis patients. Ann Clin Transl Neurol, 2, 972–7.10.1002/acn3.229CrossRef Google Scholar PubMed

Lower, E. E., Broderick, J. P., Brott, T. G., and Baughman, R. P. 1997. Diagnosis and management of neurological sarcoidosis. Arch Int Med, 157, 1864–8.CrossRef Google Scholar PubMed

Menninger, M. D., Amdur, R. J., and Marcus, R. R., 2003. Role of radiotherapy in the treatment of neurosarcoidosis. Am J Clin Oncol, 26, 115–18.10.1097/01.COC.0000077933.69101.5DCrossRef Google Scholar PubMed

Moller, D. R. and Chen, E. C. 2002a. Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex? Am J Respir Cell Mol Biol, 27, 391–5.10.1165/rcmb.2002-0164PSCrossRef Google Scholar PubMed

Moller, D. R. and Chen, E. C. 2002b. What causes sarcoidosis? Curr Opin Pulm Med, 8, 429–34.10.1097/00063198-200209000-00015CrossRef Google Scholar PubMed

Molnar, J., Nijland, M. J., Howe, D., and Nathanielsz, P. W. 2002. Evidence for microvascular dysfunction after prenatal dexamethasone at 0.7, 0.75, and 0.8 gestation in sheep. Am J Physiol Regul Integr Comp Physiol, 283, R561–7.10.1152/ajpregu.00031.2002CrossRef Google Scholar PubMed

Nakagaki, H., Furuya, J., Nagata, T., et al. 2004. An elder case of neurosarcoidosis associated with brain infarction. Rinsho Shinkeigaku, 44, 81–5.Google Scholar

Nozaki, K. and Judson, M. A., 2012. Neurosarcoidosis: Clinical manifestations, diagnosis and treatment. Presse Med, 41, e331–48.10.1016/j.lpm.2011.12.017CrossRef Google Scholar PubMed

Paleolog, E. M., Delasalle, S. A., Buurman, W. A., and Feldmann, M. 1994. Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells. Blood, 84, 2578–90.10.1182/blood.V84.8.2578.2578CrossRef Google Scholar PubMed

Rybicki, B. A., Iannuzzi, M. C., Frederick, M. M., et al. 2001. Familial aggregation of sarcoidosis: A Case-Controlled Etiologic Study of Sarcoidosis (ACCESS). Am Journal Respir Crit Care Med, 164, 2085–91.10.1164/ajrccm.164.11.2106001CrossRef Google Scholar

Sah, B. P., Goyal, S., and Iannuzzi, M. C, 2015. Novel pharmacotherapy of sarcoidosis. Pharmacol Therapeut, doi: 10.1016/j.pharmathera.2015.10.001.CrossRef Google Scholar

Sekhri, V., Sanal, S., DeLorenzo, L.J., et al., 2011. Cardiac sarcoidosis: A comprehensive review. Arch Med Sci, 7 (4), 546–554.10.5114/aoms.2011.24118CrossRef Google Scholar PubMed

Selvi, A., Diakou, M., Giannopoulos, S., et al. 2009. Cerebral venous thrombosis in a patient with sarcoidosis. Intern Med, 48, 723–725.10.2169/internalmedicine.48.1809CrossRef Google Scholar

Sethi, K. D., el Gammal, T., Patel, B. R., and Swift, T. R. 1986. Dural sarcoidosis presenting with transient neurologic symptoms. Arch Neurol, 43, 595–7.10.1001/archneur.1986.00520060057018CrossRef Google Scholar PubMed

Stern, B. J. 2004. Neurological complications of sarcoidosis. Curr Opin Neurol, 17, 311–6.10.1097/00019052-200406000-00013CrossRef Google Scholar PubMed

Taveen, J. O. and Stern, B. J. 2014. Neurosarcoidosis. Continuum (Minneap Minn), 20, 545–59.Google Scholar

Van der Poll, T., Büller, H. R., ten Cate, H., et al. 1990. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med, 322, 1622–7.10.1056/NEJM199006073222302CrossRef Google Scholar PubMed

Viles-Gonzales, J. F., Pastori, L., Fischer, A., et al., 2013. Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications. Chest, 143, 1085–1090.10.1378/chest.11-3214CrossRef Google Scholar

Zajicek, J. P., Scolding, N. J., Foster, O., et al. 1999. Central nervous system sarcoidosis: Diagnosis and management. QJ Med, 92, 103–17.10.1093/qjmed/92.2.103CrossRef Google Scholar PubMed

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.

Book contents

Section 2 - Inflammatory Conditions

Summary

Information

Access options

Book purchase

Temporarily unavailable

References

References

References

References

References

References

Accessibility standard: Unknown

Why this information is here

Accessibility Information

Save book to Kindle

Save book to Dropbox

Save book to Google Drive